《大行報告》大摩相信友邦(01299.HK)未來60日股價將上升
摩根士丹利發表技術意見報告,相信友邦保險(01299.HK)股價在未來60日會上升,料發生的可能性有60-70%,主要因為公司公布了第三季經營表現,當中新業務價值增長1%,釋除了香港社會不穩或致公司出現負增長的憂慮。
而在香港業務以外,該行指友邦季度業務增長達14%,好過預期,公司亦再度重申中國市場增長仍十分強勁,雖然受香港的不確定性影響公司增長仍面對阻礙,但市場應將焦點重新放在公司中、長期增長機遇上,特別是針對中國市場方面,予公司目標價92元,評級「增持」。 ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.